Cam Gallagher, President, Interim CFO at Zentalis Pharmaceuticals, Inc. (ZNTL), sold 19,194 shares at $11.98 ($230K) on 2024-05-31, disclosed to the SEC on 2024-05-31.
Seasonal sale ($230k) by President, Interim CFO — this insider has traded ZNTL in May in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $11.98 | 9,597 | $115K | 50.0% |
| 2 | $11.98 | 9,597 | $115K | 50.0% |
| Total | $11.98 avg | 19,194 | $230K | 100% |
| Filing → |
| ZNTL | SELL | 2024-02-05 | $267K | — | Filing → |
| ZNTL | SELL | 2023-05-31 | $1.5M | — | Filing → |
| ZNTL | SELL | 2023-02-14 | $475K | — | Filing → |